Norepinephrine reuptake inhibitors and risk of antihypertensive treatment intensification and major adverse cardiovascular events in patients with stable hypertension and depression

ConclusionsAmong patients with stable hypertension and depression, initiation of serotonin norepinephrine reuptake inhibitors had a similar risk of antihypertensive TI and MACE compared to initiation of SSRIs. Future study with a larger sample size is needed to confirm our findings.

Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - April 28, 2022 Category: Drugs & Pharmacology Authors: Raj Desai, Haesuk Park, Joshua D. Brown, Raj Mohandas, Steven M. Smith Tags: RESEARCH ARTICLE Source Type: research